Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of 10x Genomics, Inc. (TXG)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of 10x Genomics, Inc. since year 2005.
Table 2 shows the detailed insider transactions of 10x Genomics, Inc. since 2005.
The reporting company's ticker symbol is TXG. The reporting company's CIK number is 1770787.
The total value of stock buying since 2005 is $19,012,500.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $150,670.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2020-01-03||Hindson Benjamin J. (See Remarks)||Option Ex||67,500||.88||59,400|
|2019-10-14||Saxonov Serge (Chief Executive Officer)||Option Ex||22,829||4.00||91,270|
|2019-09-16||Roberts Bryan E (Director)||Buy||300,000||39.00||11,700,000|
|2019-09-12||Tananbaum James B. (10% Owner)||Buy||187,500||39.00||7,312,500|
Insider trading activities including stock purchases, stock sales, and option exercises of TXG listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of 10x Genomics, Inc. (symbol TXG, CIK number 1770787) see the Securities and Exchange Commission (SEC) website.